Catalio Capital Management Overview

  • Investor Type
  • Venture Capital
  • Status
  • Active
  • Professionals
  • 20
Professionals
  • Investments
  • 55
  • Portfolio
  • 41
  • Exits
  • 9
Exits

Catalio Capital Management General Information

Description

Founded in 2016, Catalio Capital Management is a venture capital firm based in Baltimore, Maryland. The firm seeks to invest in the software, digital health, life sciences, pharmaceuticals, and biotechnology sectors.

Contact Information

Website
www.cataliocapital.com
Formerly Known As
Nexus
Year Founded
2016
Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Primary Office
  • 24 West 25th Street
  • Suite 200
  • New York, NY 10010
  • United States
+1 (917) 000-0000

Catalio Capital Management Investments (55)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Sherlock Biosciences 08-Mar-2022 Early Stage VC 0000 Diagnostic Equipment Generating Revenue
000000 000 01-Mar-2022 00000 00000 Drug Discovery Generating Revenue
000000000 01-Mar-2022 00000 00000 Biotechnology Startup
000000 00 02-Feb-2022 00000 00000 000.00 Drug Discovery Pre-Clinical Trials
00000000000 01-Feb-2022 00000 00000 0000 Drug Discovery Stealth
00000000 00000000 01-Feb-2022 00000 00000 Decision/Risk Analysis Generating Revenue
00000 000 01-Feb-2022 00000 00000 Biotechnology Startup
000000 00000000000 01-Feb-2022 00000 00000 0000 Therapeutic Devices Stealth
Septerna 27-Jan-2022 Early Stage VC 00000 Drug Discovery Generating Revenue
Hyperfine (Diagnostic Equipment) 22-Dec-2021 PIPE 00000 Diagnostic Equipment Generating Revenue
You’re viewing 10 of 55 investments. Get the full list »
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Catalio Capital Management Exits (9)

Company Name Exit Date Exit Type Exit Size
Personal Genome Diagnostics 21-Feb-2022 Merger/Acquisition 00000
0000 0000 00000000 18-Jun-2021 000 00000
00000000 00000000 27-May-2021 000 00000
000000000 16-Apr-2021 000 00000
000000 00000000000 04-Feb-2021 000 00000
000000 0000000 000 05-Jan-2021 000000000000000000 00.000
000000000 11-Dec-2020 000 00000
COMPASS Pathways 18-Sep-2020 IPO 00000
Ashvattha Therapeutics 01-Jan-2019 Secondary Transaction - Private
To view Catalio Capital Management’s complete exits history, request access »

Catalio Capital Management Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Catalio Capital Management Team (66)

Name Title Deals Funds Boards Office
George Petrocheilos Co-Founder & Managing Partner 0 0 0 New York, NY
Kenan Turnacioglu Ph.D General Partner and Investment Committee Member 0 0 0 New York, NY
Josh Samuelson General Partner New York, NY
Thomas Brooks General Partner and Member of the Investment Committee 0 0 0 New York, NY
Adam Riess Ph.D Venture Partner New York, NY
You’re viewing 5 of 66 team members. Get the full list »

Catalio Capital Management Co-Investors (265)

Name With Exits Lead Partner Series Industry
Casdin Capital 7 0 0 Series chart Industry bar
Polaris Partners 0 0 Series chart Industry bar
ARCH Venture Partners 0 0 Series chart Industry bar
GV 0 0 Series chart Industry bar
The Invus Group 0 0 Series chart Industry bar
You’re viewing 5 of 265 co-investors. Get the full list »